A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to long-lasting T cell expansion and no disease recurrence after 40 months.
Neoantigen vaccine sparks powerful immune defense against kidney cancer
- Post author:admin
- Post published:February 6, 2025
- Post category:uncategorized
- Post comments:0 Comments